Senior Clinical Trial Associate (Sr. CTA)
Required skills
- TMF
- CRO
- Clinical Supply
- Lab Sample Coordination
- Data Reconciliation
- MS Word
- MS Excel
- MS Outlook
- MS PowerPoint
Nice to have
- AI-integrated discovery engine
- targeted protein degradation
Role summary
Nurix Therapeutics is seeking a Senior Clinical Trial Associate (Sr. CTA) to manage clinical trials end-to-end, focusing on TMF integrity and vendor coordination. This role involves developing, tracking, and archiving essential documents, leading quality reviews, and resolving discrepancies with CROs. The Sr. CTA will also mentor junior team members, manage clinical supply and lab sample coordination, and handle data reconciliation. Proficiency in MS Office Suite and excellent communication skills are required. The position is based onsite in Brisbane, CA, with a salary range of $134,500 - $146,600 annually.
Senior Clinical Trial Associate (Sr. CTA) NX-1607
You’ve done this before — now do it with more ownership. You’ll run the TMF for your studies end-to-end, work directly with CROs to resolve problems before they become problems, and help the CTAs around you get better at the job.
Position Description
You’ll independently own key operational pieces of our trials — from TMF integrity to vendor coordination — and mentor junior team members along the way.
The Opportunity
What You’ll Bring
Salary Range: $134,500 - $146,600 annually
The posted range applies to roles based in the San Francisco Bay Area and reflects local market conditions. Where an offer lands within that range depends on the candidate’s relevant experience, technical expertise, and how their background aligns with the role’s requirements.
Location: Onsite - Brisbane, CA
Fit with Nurix Culture and Values
About Nurix Therapeutics
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix’s dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine’s next chapter with a new script to outmatch disease.
